Dr. Kenneth Kalunian discusses the Lupus Foundation of America Collective Data Analysis Initiative (LFA CDAI) which is providing insight into the impact various background medications may have on lupus clinical trial outcomes.
Human Mesenchymal Stem Cells as a Potential Therapy for Lupus
Dr. Gary Gilkeson of the Medical University of South Carolina has received a research grant from the Lupus Foundation of America to study human mesenchymal stem cells as a potential therapy for lupus. Dr. Gilkeson also chairs the Lupus Foundation of America Medical-Scientific Advisory Council. In this podcast, Dr. Gilkeson discusses his research project and the potential benefits of this therapy.
Presented: Gary S. Gilkeson, MD
Presentation Date: November 4, 2013
Length: 7 minutes
Study examines the effects of the antimalarial drug, hydroxycloroquine, on antiphospholipid antibodies that are responsible for pregnancy complications in women with lupus and antiphospholipid syndrome.